Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...
The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust ...
Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...
Science Corporation published preliminary data Tuesday from a late stage, multi-center clinical trial of a retina implant that showed promising results. Using this prosthetic, scientists partially ...
A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...
To date, Vabysmo is approved in more than 100 countries for DME and wet, or neovascular, age-related macular degeneration ...
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...
Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Sept. 9 in Scientific Reports. Je Moon Yoon, from ...
Macular degeneration is a nasty disease of the eye causing loss of vision as the center of the retina deteriorates.
Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback